TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Picard Medical, Inc. ( (PMI) ) is now available.
On December 4, 2025, Picard Medical, Inc. presented in vitro data on their Emperor Total Artificial Heart at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support in Vienna. The Emperor TAH demonstrated comparable autoregulation and afterload independence to the pneumatic SynCardia Total Artificial Heart, showcasing its potential for stable hemodynamic performance and surgical feasibility in acute in vivo tests, which could pave the way for future clinical applications.
More about Picard Medical, Inc.
Picard Medical, Inc. operates in the medical device industry, focusing on developing advanced artificial heart technologies. Their primary product, the Emperor Total Artificial Heart, is a motor-driven evolution of the SynCardia Total Artificial Heart, designed to provide robust circulatory support for patients with end-stage biventricular heart failure.
Average Trading Volume: 2,044,057
See more data about PMI stock on TipRanks’ Stock Analysis page.